Results 91 to 100 of about 11,231 (185)

The use of micafungin in neonates and children: A systematic review

European Journal of Volunteering and Community-Based Projects, 2020
BACKGROUNG: About 10% of newborns under 1000 g have problems related to candidiasis. The mortality rate is still very high today, and new types of drugs are used for the treatment.
Silvana Secinaro, Valerio Brescia, Davide Calandra, Giovanni Paride Verardi, Fabrizio Bert   +4 more
doaj   +2 more sources

Micafungin Concentrations in the Plasma and Burn Eschar of Severely Burned Patients

, 2012
Micafungin concentrations in plasma and burn eschar after daily intravenous infusion (1 h) of micafungin (200 to 300 mg) were investigated for six patients with severe burns. Micafungin treatment was initiated more than 72 h after the burn injuries.
Yotaro Shinozawa, Satoshi Kishino, Shingo Hori, Daisuke Kudo, Shigeki Kushimoto, Tomoyuki Endo, Junichi Sasaki, Ryosuke Nomura, Naoki Aikawa, Satoshi Yamanouchi, Kiyotsugu Takuma   +10 more
core   +1 more source

Micafungin in the treatment of candiduria: A case series

, 2016
Echinocandin antifungal agents are not routinely recommended for the treatment of candiduria due to low urine concentrations and a paucity of clinical data supporting this indication.
Lauren E. Kane, Katie M. Muzevich
core   +1 more source

Population pharmacokinetics of micafungin in neonates and young infants

, 2010
Micafungin is an echinocandin with potent activity against Candida spp. Hematogenous Candida meningoencephalitis (HCME) is a frequent complication of disseminated Candida infection in premature infants.
M. Roy, Kaibara, Atsunori, D. N. Buell, A. Kaibara, Cohen-Wolkowiez, Michael, Walsh, Thomas J., Smith, P. Brian, M. Cohen-Wolkowiez, T. J. Walsh, D. K. Benjamin, W. W. Hope, P. B. Smith, Roy, Michael, Buell, Donald N., Hope, William W., Arrieta, Antonio, Benjamin, Daniel K., A. Arrieta   +17 more
core   +1 more source

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin [PDF]

, 2018
Micafungin is a selective inhibitor of the synthesis of fungal 1,3-beta-D-glucan, an essential component of the fungal cell wall. It is available as a powder for infusion only and is registered for the treatment of invasive and esophageal candidiasis in ...
Burger, D.M., Bruggemann, R.J., Wasmann, R.E., Muilwijk, E.W., Knibbe, C.A., Bruggemann, R.J.M., Knibbe, C.A.J., Verweij, P.E.   +7 more
core   +2 more sources

INVASIVE FUNGAL INFECTIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (TCTH) RECIPIENTS UNDER ANTIFUNGAL PROPHYLAXIS WITH ECHINOCANDIN: BRAZILIAN EXPERIENCE

Brazilian Journal of Infectious Diseases
Introduction: Onco-hematologic patients undergoing TCTH are at high risk for invasive fungal infections (IFI), one of the main causes of morbidity and mortality in this population.
Jessica Fernandes Ramos, Raissa Nathalia Bordin, Danilo Belchior Ponciano, Maria Cristina Nunez Seiwald, Anita Cassoli Cortez, Aliana Meneses Ferreira, Ana Rita Fonseca, Simone Ojima Ferreira, Yana A Novis   +8 more
doaj   +1 more source

Economic contributions of pharmaceutical interventions by pharmacists: a retrospective report in Japan

Journal of Pharmaceutical Policy and Practice, 2017
Background Pharmacists in Japan currently play a key role in patient hospital care. Their responsibilities include filling prescriptions, checking a patient’s medication history, and providing appropriate information to other health care workers.
Daiki Yasunaga, Yuichi Tasaka, Satoshi Murakami, Akihiro Tanaka, Mamoru Tanaka, Hiroaki Araki   +5 more
doaj   +1 more source

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature

European Journal of Medical Research, 2011
Echinocandins represent the newest class of antifungal agents. Currently, three echinocandins, anidulafungin, caspofungin and micafungin are licensed for clinical use in various indications.
Kofla G, Ruhnke M
doaj   +1 more source

Response to other antifungal drugs of micafungin-sensitive mutants.

, 2013
(A) Representative examples of micafungin-sensitive mutants that showed varying levels of sensitivity to AmB. Cells were spotted onto plates containing YES or YES plus 20 µg/ml AmB and incubated at 27°C for 4 days.
Yuki Yamada (104430), Yan Ma (88810), Xin Zhou (54275), Yue Fang (124565), Wugan gerile (416548), Wurentuya Jaiseng (124568), Takayoshi Kuno (124570)   +6 more
core   +1 more source

Micafungin induced apoptosis in candida parapsilosis independent of its susceptibility to micafungin

, 2015
We hypothesized that the cell wall inhibitor micafungin (MICA) induces apoptosis in both MICA-susceptible (MICA-S) and MICA–non-susceptible (MICA-NS) Candida parapsilosis.
Kontoyiannis D. P., Shirazi F., Lewis R. E.   +2 more
core   +1 more source